THE FUNCTIONAL CONSEQUENCES OF INHIBITION OF MONOAMINE-OXIDASE TYPE-B - COMPARISON OF THE PHARMACOLOGICAL PROPERTIES OF L-DEPRENYL AND MDL-72145

被引:32
作者
FOZARD, JR
ZREIKA, M
ROBIN, M
PALFREYMAN, MG
机构
关键词
D O I
10.1007/BF00634237
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:186 / 193
页数:8
相关论文
共 38 条
  • [1] BEY P, 1984, British Journal of Pharmacology, V81, p50P
  • [2] (E)-2-(3,4-DIMETHOXYPHENYL)-3-FLUOROALLYLAMINE - A SELECTIVE, ENZYME-ACTIVATED INHIBITOR OF TYPE-B MONOAMINE-OXIDASE
    BEY, P
    FOZARD, J
    LACOSTE, JM
    MCDONALD, IA
    ZREIKA, M
    PALFREYMAN, MG
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (01) : 9 - 10
  • [3] (-)DEPRENYL IN THE TREATMENT OF PARKINSONS-DISEASE
    BIRKMAYER, W
    RIEDERER, P
    YOUDIM, MBH
    [J]. CLINICAL NEUROPHARMACOLOGY, 1982, 5 (02) : 195 - 230
  • [4] ADVERSE-EFFECTS OF ANTI-DEPRESSANT DRUGS .1. MONOAMINE-OXIDASE INHIBITORS AND TRICYCLICS
    BLACKWELL, B
    [J]. DRUGS, 1981, 21 (03) : 201 - 219
  • [6] DENES B, 1984, ARZNEIMITTEL-FORSCH, V34-1, P266
  • [7] DEPRENYL ADMINISTRATION IN MAN - SELECTIVE MONO-AMINE OXIDASE-B INHIBITOR WITHOUT CHEESE EFFECT
    ELSWORTH, JD
    GLOVER, V
    REYNOLDS, GP
    SANDLER, M
    LEES, AJ
    PHUAPRADIT, P
    SHAW, KM
    STERN, GM
    KUMAR, P
    [J]. PSYCHOPHARMACOLOGY, 1978, 57 (01) : 33 - 38
  • [8] THE CONTRIBUTION OF AMPHETAMINE METABOLITES OF (-)-DEPRENYL TO ITS ANTIPARKINSONIAN PROPERTIES
    ELSWORTH, JD
    SANDLER, M
    LEES, AJ
    WARD, C
    STERN, GM
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1982, 54 (1-2) : 105 - 110
  • [9] RELATIONSHIP BETWEEN TYRAMINE POTENTIATION AND SELECTIVE-INHIBITION OF MONOAMINE-OXIDASE TYPE-A AND TYPE-B IN THE RAT VAS-DEFERENS
    FINBERG, JPM
    TENNE, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1982, 77 (01) : 13 - 21
  • [10] FOWLER C J, 1982, Drugs of the Future, V7, P501